VACCINEX, INC. (VCNX)
CIK 1205922 · all EDGAR filings →
Same rating bands the category standard uses, but free, with the formula on the chip and the gaps in the data said out loud.
Shares outstanding over time
Latest: 2.7M shares as of Apr 11, 2025 (10-K).⊙
Cash runway
~1 month of cash left
critical · burning $4.0M / quarter
Full breakdown: cash runway tool · source filing →
Warrants
| Tranche | Warrants | Exercise price | Term | Notes |
|---|---|---|---|---|
| New Warrants | 1.6M | $5.636 | — | — |
| Existing Warrants | 1.1M | $5.636 | — | — |
| Pre Funded Warrants | 584,646 | not tagged | — | — |
| Public Warrants | 542,857 | not tagged | 5y | — |
| Common Warrants | 193,000 | $14 | — | — |
| Pre Funded Warrants and Public Warrants | 142,857 | not tagged | — | — |
| Common Warrants Two | 142,857 | not tagged | — | — |
| Common and Pre Funded Warrants | 90,363 | not tagged | — | — |
| Private Placement Warrants | 37,694 | not tagged | 5y | — |
Tranches exactly as the company dimensioned them in its 10-K filed Apr 15, 2025 →. Groupings can overlap (a “Series E and F” row is not additive with a “Series E” row), so do not sum this column. A tranche the filer did not tag is absent here, not absent from the cap table. DOWN-ROUND = the filer tagged price-protection accounting scoped to that tranche.
No warrant figures tagged in this filer’s XBRL facts. That means the company has not reported them in structured form; it does not prove no warrants exist. The exhibits are the ground truth.
Convertible notes
No convertible-note facts tagged in the 10-K filed Apr 15, 2025. If convertible notes exist, their terms live in exhibit prose for this filer and are not parsed; absence of a tag is not proof of absence. The exhibits are the ground truth.
Fully diluted build-up
Shares outstanding plus every potential-share instrument the filer tagged in XBRL, each at its own as-of date. An estimate assembled from filed figures, not a filing figure itself.
| Shares outstanding | 2.7M | Apr 11, 2025 |
| + New Warrants (if exercised) | 1.6M | Sep 17, 2024 |
| + Existing Warrants (if exercised) | 1.1M | Sep 17, 2024 |
| + Pre Funded Warrants (if exercised) | 584,646 | Nov 13, 2024 |
| + Public Warrants (if exercised) | 542,857 | Oct 3, 2023 |
| + Common Warrants (if exercised) | 193,000 | Mar 27, 2024 |
| + Pre Funded Warrants and Public Warrants (if exercised) | 142,857 | Oct 3, 2023 |
| + Common Warrants Two (if exercised) | 142,857 | Oct 3, 2023 |
| + Common and Pre Funded Warrants (if exercised) | 90,363 | Feb 6, 2024 |
| + Private Placement Warrants (if exercised) | 37,694 | Nov 30, 2023 |
| Fully diluted estimate | 7.1M | +164.5% vs O/S |
Still excluded, because the filer does not tag them in countable form: employee options and RSUs, any instrument living only in exhibit prose, and instruments above missing a share count. Inputs carry different as-of dates, shown per row. Each figure traces to the tranche and note tables above and their cited filings.
Registrations and offerings
Last 12 months: 0 executed · 0 registered.
Full history and shelf status: offering checker · S-3 shelf checker
Source: SEC EDGAR XBRL company facts and filing metadata, fetched live and cached briefly. Share counts are cover-page figures with their form named. Warrant tranches and convertible notes come from the dimensioned facts in the latest 10-Q/10-K instance document, exactly as the company tagged them; untagged tranches and notes are absent, not disproven. Nothing on this page is manually verified and nothing is behind a login: what free data supports is shown, what it cannot support is stated. Not investment advice.
Keep going: float checker · offering calendar · short-squeeze screener · full VCNX workspace
Free to use. No account, no card.